Global Natural Killer Cell Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
NK cells, a type of immune cell, have received a lot of attention for their natural capacity to recognize and kill malignant cells. Advances in understanding NK cell biology and its interactions with Cancer have resulted in the development of new medicines that harness the potential of these cells. With the success of CAR-NK cell therapies in preclinical and early clinical trials, there is growing optimism about the ability of NK cell-based immunotherapies to treat a wide spectrum of cancer types.
The global Natural Killer Cell Therapeutics market size is projected to grow from US$ 184 million in 2024 to US$ 1418 million in 2030; it is expected to grow at a CAGR of 40.6% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Natural Killer Cell Therapeutics Industry Forecast” looks at past sales and reviews total world Natural Killer Cell Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Natural Killer Cell Therapeutics sales for 2023 through 2029. With Natural Killer Cell Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Natural Killer Cell Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Natural Killer Cell Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Natural Killer Cell Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Natural Killer Cell Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Natural Killer Cell Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Natural Killer Cell Therapeutics.
Another important driver for the NK Cell Therapeutics Market is the rising global prevalence of Cancer, combined with ongoing unmet medical needs in cancer treatment. Despite advances in traditional medicines such as chemotherapy and targeted therapy, certain malignancies continue to be refractory or develop treatment resistance. This highlights the critical need for novel therapeutic approaches, such as NK cell-based immunotherapy, which has the potential to improve efficacy while reducing adverse effects. As the cancer burden grows, fuelled by factors such as aging populations and lifestyle changes, there is an increasing need to discover effective medicines, driving demand for NK cell therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer Cell Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
NK cells, a type of immune cell, have received a lot of attention for their natural capacity to recognize and kill malignant cells. Advances in understanding NK cell biology and its interactions with Cancer have resulted in the development of new medicines that harness the potential of these cells. With the success of CAR-NK cell therapies in preclinical and early clinical trials, there is growing optimism about the ability of NK cell-based immunotherapies to treat a wide spectrum of cancer types.
The global Natural Killer Cell Therapeutics market size is projected to grow from US$ 184 million in 2024 to US$ 1418 million in 2030; it is expected to grow at a CAGR of 40.6% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Natural Killer Cell Therapeutics Industry Forecast” looks at past sales and reviews total world Natural Killer Cell Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Natural Killer Cell Therapeutics sales for 2023 through 2029. With Natural Killer Cell Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Natural Killer Cell Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Natural Killer Cell Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Natural Killer Cell Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Natural Killer Cell Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Natural Killer Cell Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Natural Killer Cell Therapeutics.
Another important driver for the NK Cell Therapeutics Market is the rising global prevalence of Cancer, combined with ongoing unmet medical needs in cancer treatment. Despite advances in traditional medicines such as chemotherapy and targeted therapy, certain malignancies continue to be refractory or develop treatment resistance. This highlights the critical need for novel therapeutic approaches, such as NK cell-based immunotherapy, which has the potential to improve efficacy while reducing adverse effects. As the cancer burden grows, fuelled by factors such as aging populations and lifestyle changes, there is an increasing need to discover effective medicines, driving demand for NK cell therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer Cell Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- NK Cell Therapies
- NK Cell Directed Antibodies
- Research & Academic Institutes
- Hospitals
- Specialty Clinics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- NK Cell Therapies
- NK Cell Directed Antibodies
- Research & Academic Institutes
- Hospitals
- Specialty Clinics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck KGaA
- Bristol-Myers Squibb Company
- Glycostem
- Sanofi
- Cytovia Therapeutics
- ImmunityBio, Inc.
- Biohaven Pharmaceuticals
- Fate Therapeutics
- EMERcell
- Phio Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Natural Killer Cell Therapeutics Market Size 2019-2030
2.1.2 Natural Killer Cell Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Natural Killer Cell Therapeutics by Country/Region, 2019, 2023 & 2030
2.2 Natural Killer Cell Therapeutics Segment by Type
2.2.1 NK Cell Therapies
2.2.2 NK Cell Directed Antibodies
2.3 Natural Killer Cell Therapeutics Market Size by Type
2.3.1 Natural Killer Cell Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Natural Killer Cell Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Natural Killer Cell Therapeutics Segment by Application
2.4.1 Research & Academic Institutes
2.4.2 Hospitals
2.4.3 Specialty Clinics
2.5 Natural Killer Cell Therapeutics Market Size by Application
2.5.1 Natural Killer Cell Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Natural Killer Cell Therapeutics Market Size Market Share by Application (2019-2024)
3 NATURAL KILLER CELL THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Natural Killer Cell Therapeutics Market Size Market Share by Player
3.1.1 Global Natural Killer Cell Therapeutics Revenue by Player (2019-2024)
3.1.2 Global Natural Killer Cell Therapeutics Revenue Market Share by Player (2019-2024)
3.2 Global Natural Killer Cell Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NATURAL KILLER CELL THERAPEUTICS BY REGION
4.1 Natural Killer Cell Therapeutics Market Size by Region (2019-2024)
4.2 Global Natural Killer Cell Therapeutics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Natural Killer Cell Therapeutics Market Size Growth (2019-2024)
4.4 APAC Natural Killer Cell Therapeutics Market Size Growth (2019-2024)
4.5 Europe Natural Killer Cell Therapeutics Market Size Growth (2019-2024)
4.6 Middle East & Africa Natural Killer Cell Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Natural Killer Cell Therapeutics Market Size by Country (2019-2024)
5.2 Americas Natural Killer Cell Therapeutics Market Size by Type (2019-2024)
5.3 Americas Natural Killer Cell Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Natural Killer Cell Therapeutics Market Size by Region (2019-2024)
6.2 APAC Natural Killer Cell Therapeutics Market Size by Type (2019-2024)
6.3 APAC Natural Killer Cell Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Natural Killer Cell Therapeutics Market Size by Country (2019-2024)
7.2 Europe Natural Killer Cell Therapeutics Market Size by Type (2019-2024)
7.3 Europe Natural Killer Cell Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Natural Killer Cell Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET FORECAST
10.1 Global Natural Killer Cell Therapeutics Forecast by Region (2025-2030)
10.1.1 Global Natural Killer Cell Therapeutics Forecast by Region (2025-2030)
10.1.2 Americas Natural Killer Cell Therapeutics Forecast
10.1.3 APAC Natural Killer Cell Therapeutics Forecast
10.1.4 Europe Natural Killer Cell Therapeutics Forecast
10.1.5 Middle East & Africa Natural Killer Cell Therapeutics Forecast
10.2 Americas Natural Killer Cell Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Market Natural Killer Cell Therapeutics Forecast
10.2.2 Canada Market Natural Killer Cell Therapeutics Forecast
10.2.3 Mexico Market Natural Killer Cell Therapeutics Forecast
10.2.4 Brazil Market Natural Killer Cell Therapeutics Forecast
10.3 APAC Natural Killer Cell Therapeutics Forecast by Region (2025-2030)
10.3.1 China Natural Killer Cell Therapeutics Market Forecast
10.3.2 Japan Market Natural Killer Cell Therapeutics Forecast
10.3.3 Korea Market Natural Killer Cell Therapeutics Forecast
10.3.4 Southeast Asia Market Natural Killer Cell Therapeutics Forecast
10.3.5 India Market Natural Killer Cell Therapeutics Forecast
10.3.6 Australia Market Natural Killer Cell Therapeutics Forecast
10.4 Europe Natural Killer Cell Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Market Natural Killer Cell Therapeutics Forecast
10.4.2 France Market Natural Killer Cell Therapeutics Forecast
10.4.3 UK Market Natural Killer Cell Therapeutics Forecast
10.4.4 Italy Market Natural Killer Cell Therapeutics Forecast
10.4.5 Russia Market Natural Killer Cell Therapeutics Forecast
10.5 Middle East & Africa Natural Killer Cell Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Market Natural Killer Cell Therapeutics Forecast
10.5.2 South Africa Market Natural Killer Cell Therapeutics Forecast
10.5.3 Israel Market Natural Killer Cell Therapeutics Forecast
10.5.4 Turkey Market Natural Killer Cell Therapeutics Forecast
10.6 Global Natural Killer Cell Therapeutics Forecast by Type (2025-2030)
10.7 Global Natural Killer Cell Therapeutics Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Natural Killer Cell Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Merck KGaA
11.1.1 Merck KGaA Company Information
11.1.2 Merck KGaA Natural Killer Cell Therapeutics Product Offered
11.1.3 Merck KGaA Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Merck KGaA Main Business Overview
11.1.5 Merck KGaA Latest Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Information
11.2.2 Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Product Offered
11.2.3 Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bristol-Myers Squibb Company Main Business Overview
11.2.5 Bristol-Myers Squibb Company Latest Developments
11.3 Glycostem
11.3.1 Glycostem Company Information
11.3.2 Glycostem Natural Killer Cell Therapeutics Product Offered
11.3.3 Glycostem Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Glycostem Main Business Overview
11.3.5 Glycostem Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Natural Killer Cell Therapeutics Product Offered
11.4.3 Sanofi Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Cytovia Therapeutics
11.5.1 Cytovia Therapeutics Company Information
11.5.2 Cytovia Therapeutics Natural Killer Cell Therapeutics Product Offered
11.5.3 Cytovia Therapeutics Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cytovia Therapeutics Main Business Overview
11.5.5 Cytovia Therapeutics Latest Developments
11.6 ImmunityBio, Inc.
11.6.1 ImmunityBio, Inc. Company Information
11.6.2 ImmunityBio, Inc. Natural Killer Cell Therapeutics Product Offered
11.6.3 ImmunityBio, Inc. Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 ImmunityBio, Inc. Main Business Overview
11.6.5 ImmunityBio, Inc. Latest Developments
11.7 Biohaven Pharmaceuticals
11.7.1 Biohaven Pharmaceuticals Company Information
11.7.2 Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Product Offered
11.7.3 Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biohaven Pharmaceuticals Main Business Overview
11.7.5 Biohaven Pharmaceuticals Latest Developments
11.8 Fate Therapeutics
11.8.1 Fate Therapeutics Company Information
11.8.2 Fate Therapeutics Natural Killer Cell Therapeutics Product Offered
11.8.3 Fate Therapeutics Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Fate Therapeutics Main Business Overview
11.8.5 Fate Therapeutics Latest Developments
11.9 EMERcell
11.9.1 EMERcell Company Information
11.9.2 EMERcell Natural Killer Cell Therapeutics Product Offered
11.9.3 EMERcell Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 EMERcell Main Business Overview
11.9.5 EMERcell Latest Developments
11.10 Phio Pharmaceuticals
11.10.1 Phio Pharmaceuticals Company Information
11.10.2 Phio Pharmaceuticals Natural Killer Cell Therapeutics Product Offered
11.10.3 Phio Pharmaceuticals Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Phio Pharmaceuticals Main Business Overview
11.10.5 Phio Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Natural Killer Cell Therapeutics Market Size 2019-2030
2.1.2 Natural Killer Cell Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Natural Killer Cell Therapeutics by Country/Region, 2019, 2023 & 2030
2.2 Natural Killer Cell Therapeutics Segment by Type
2.2.1 NK Cell Therapies
2.2.2 NK Cell Directed Antibodies
2.3 Natural Killer Cell Therapeutics Market Size by Type
2.3.1 Natural Killer Cell Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Natural Killer Cell Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Natural Killer Cell Therapeutics Segment by Application
2.4.1 Research & Academic Institutes
2.4.2 Hospitals
2.4.3 Specialty Clinics
2.5 Natural Killer Cell Therapeutics Market Size by Application
2.5.1 Natural Killer Cell Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Natural Killer Cell Therapeutics Market Size Market Share by Application (2019-2024)
3 NATURAL KILLER CELL THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Natural Killer Cell Therapeutics Market Size Market Share by Player
3.1.1 Global Natural Killer Cell Therapeutics Revenue by Player (2019-2024)
3.1.2 Global Natural Killer Cell Therapeutics Revenue Market Share by Player (2019-2024)
3.2 Global Natural Killer Cell Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NATURAL KILLER CELL THERAPEUTICS BY REGION
4.1 Natural Killer Cell Therapeutics Market Size by Region (2019-2024)
4.2 Global Natural Killer Cell Therapeutics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Natural Killer Cell Therapeutics Market Size Growth (2019-2024)
4.4 APAC Natural Killer Cell Therapeutics Market Size Growth (2019-2024)
4.5 Europe Natural Killer Cell Therapeutics Market Size Growth (2019-2024)
4.6 Middle East & Africa Natural Killer Cell Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Natural Killer Cell Therapeutics Market Size by Country (2019-2024)
5.2 Americas Natural Killer Cell Therapeutics Market Size by Type (2019-2024)
5.3 Americas Natural Killer Cell Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Natural Killer Cell Therapeutics Market Size by Region (2019-2024)
6.2 APAC Natural Killer Cell Therapeutics Market Size by Type (2019-2024)
6.3 APAC Natural Killer Cell Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Natural Killer Cell Therapeutics Market Size by Country (2019-2024)
7.2 Europe Natural Killer Cell Therapeutics Market Size by Type (2019-2024)
7.3 Europe Natural Killer Cell Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Natural Killer Cell Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET FORECAST
10.1 Global Natural Killer Cell Therapeutics Forecast by Region (2025-2030)
10.1.1 Global Natural Killer Cell Therapeutics Forecast by Region (2025-2030)
10.1.2 Americas Natural Killer Cell Therapeutics Forecast
10.1.3 APAC Natural Killer Cell Therapeutics Forecast
10.1.4 Europe Natural Killer Cell Therapeutics Forecast
10.1.5 Middle East & Africa Natural Killer Cell Therapeutics Forecast
10.2 Americas Natural Killer Cell Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Market Natural Killer Cell Therapeutics Forecast
10.2.2 Canada Market Natural Killer Cell Therapeutics Forecast
10.2.3 Mexico Market Natural Killer Cell Therapeutics Forecast
10.2.4 Brazil Market Natural Killer Cell Therapeutics Forecast
10.3 APAC Natural Killer Cell Therapeutics Forecast by Region (2025-2030)
10.3.1 China Natural Killer Cell Therapeutics Market Forecast
10.3.2 Japan Market Natural Killer Cell Therapeutics Forecast
10.3.3 Korea Market Natural Killer Cell Therapeutics Forecast
10.3.4 Southeast Asia Market Natural Killer Cell Therapeutics Forecast
10.3.5 India Market Natural Killer Cell Therapeutics Forecast
10.3.6 Australia Market Natural Killer Cell Therapeutics Forecast
10.4 Europe Natural Killer Cell Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Market Natural Killer Cell Therapeutics Forecast
10.4.2 France Market Natural Killer Cell Therapeutics Forecast
10.4.3 UK Market Natural Killer Cell Therapeutics Forecast
10.4.4 Italy Market Natural Killer Cell Therapeutics Forecast
10.4.5 Russia Market Natural Killer Cell Therapeutics Forecast
10.5 Middle East & Africa Natural Killer Cell Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Market Natural Killer Cell Therapeutics Forecast
10.5.2 South Africa Market Natural Killer Cell Therapeutics Forecast
10.5.3 Israel Market Natural Killer Cell Therapeutics Forecast
10.5.4 Turkey Market Natural Killer Cell Therapeutics Forecast
10.6 Global Natural Killer Cell Therapeutics Forecast by Type (2025-2030)
10.7 Global Natural Killer Cell Therapeutics Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Natural Killer Cell Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Merck KGaA
11.1.1 Merck KGaA Company Information
11.1.2 Merck KGaA Natural Killer Cell Therapeutics Product Offered
11.1.3 Merck KGaA Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Merck KGaA Main Business Overview
11.1.5 Merck KGaA Latest Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Information
11.2.2 Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Product Offered
11.2.3 Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bristol-Myers Squibb Company Main Business Overview
11.2.5 Bristol-Myers Squibb Company Latest Developments
11.3 Glycostem
11.3.1 Glycostem Company Information
11.3.2 Glycostem Natural Killer Cell Therapeutics Product Offered
11.3.3 Glycostem Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Glycostem Main Business Overview
11.3.5 Glycostem Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Natural Killer Cell Therapeutics Product Offered
11.4.3 Sanofi Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 Cytovia Therapeutics
11.5.1 Cytovia Therapeutics Company Information
11.5.2 Cytovia Therapeutics Natural Killer Cell Therapeutics Product Offered
11.5.3 Cytovia Therapeutics Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cytovia Therapeutics Main Business Overview
11.5.5 Cytovia Therapeutics Latest Developments
11.6 ImmunityBio, Inc.
11.6.1 ImmunityBio, Inc. Company Information
11.6.2 ImmunityBio, Inc. Natural Killer Cell Therapeutics Product Offered
11.6.3 ImmunityBio, Inc. Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 ImmunityBio, Inc. Main Business Overview
11.6.5 ImmunityBio, Inc. Latest Developments
11.7 Biohaven Pharmaceuticals
11.7.1 Biohaven Pharmaceuticals Company Information
11.7.2 Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Product Offered
11.7.3 Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biohaven Pharmaceuticals Main Business Overview
11.7.5 Biohaven Pharmaceuticals Latest Developments
11.8 Fate Therapeutics
11.8.1 Fate Therapeutics Company Information
11.8.2 Fate Therapeutics Natural Killer Cell Therapeutics Product Offered
11.8.3 Fate Therapeutics Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Fate Therapeutics Main Business Overview
11.8.5 Fate Therapeutics Latest Developments
11.9 EMERcell
11.9.1 EMERcell Company Information
11.9.2 EMERcell Natural Killer Cell Therapeutics Product Offered
11.9.3 EMERcell Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 EMERcell Main Business Overview
11.9.5 EMERcell Latest Developments
11.10 Phio Pharmaceuticals
11.10.1 Phio Pharmaceuticals Company Information
11.10.2 Phio Pharmaceuticals Natural Killer Cell Therapeutics Product Offered
11.10.3 Phio Pharmaceuticals Natural Killer Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Phio Pharmaceuticals Main Business Overview
11.10.5 Phio Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Natural Killer Cell Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Natural Killer Cell Therapeutics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of NK Cell Therapies
Table 4. Major Players of NK Cell Directed Antibodies
Table 5. Natural Killer Cell Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global Natural Killer Cell Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 7. Global Natural Killer Cell Therapeutics Market Size Market Share by Type (2019-2024)
Table 8. Natural Killer Cell Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Natural Killer Cell Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 10. Global Natural Killer Cell Therapeutics Market Size Market Share by Application (2019-2024)
Table 11. Global Natural Killer Cell Therapeutics Revenue by Player (2019-2024) & ($ millions)
Table 12. Global Natural Killer Cell Therapeutics Revenue Market Share by Player (2019-2024)
Table 13. Natural Killer Cell Therapeutics Key Players Head office and Products Offered
Table 14. Natural Killer Cell Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Natural Killer Cell Therapeutics Market Size by Region (2019-2024) & ($ millions)
Table 18. Global Natural Killer Cell Therapeutics Market Size Market Share by Region (2019-2024)
Table 19. Global Natural Killer Cell Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Natural Killer Cell Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Natural Killer Cell Therapeutics Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas Natural Killer Cell Therapeutics Market Size Market Share by Country (2019-2024)
Table 23. Americas Natural Killer Cell Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas Natural Killer Cell Therapeutics Market Size Market Share by Type (2019-2024)
Table 25. Americas Natural Killer Cell Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas Natural Killer Cell Therapeutics Market Size Market Share by Application (2019-2024)
Table 27. APAC Natural Killer Cell Therapeutics Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC Natural Killer Cell Therapeutics Market Size Market Share by Region (2019-2024)
Table 29. APAC Natural Killer Cell Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC Natural Killer Cell Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe Natural Killer Cell Therapeutics Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe Natural Killer Cell Therapeutics Market Size Market Share by Country (2019-2024)
Table 33. Europe Natural Killer Cell Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe Natural Killer Cell Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Natural Killer Cell Therapeutics
Table 39. Key Market Challenges & Risks of Natural Killer Cell Therapeutics
Table 40. Key Industry Trends of Natural Killer Cell Therapeutics
Table 41. Global Natural Killer Cell Therapeutics Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global Natural Killer Cell Therapeutics Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global Natural Killer Cell Therapeutics Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global Natural Killer Cell Therapeutics Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. Merck KGaA Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 46. Merck KGaA Natural Killer Cell Therapeutics Product Offered
Table 47. Merck KGaA Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. Merck KGaA Main Business
Table 49. Merck KGaA Latest Developments
Table 50. Bristol-Myers Squibb Company Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 51. Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Product Offered
Table 52. Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Bristol-Myers Squibb Company Main Business
Table 54. Bristol-Myers Squibb Company Latest Developments
Table 55. Glycostem Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 56. Glycostem Natural Killer Cell Therapeutics Product Offered
Table 57. Glycostem Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Glycostem Main Business
Table 59. Glycostem Latest Developments
Table 60. Sanofi Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 61. Sanofi Natural Killer Cell Therapeutics Product Offered
Table 62. Sanofi Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Sanofi Main Business
Table 64. Sanofi Latest Developments
Table 65. Cytovia Therapeutics Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 66. Cytovia Therapeutics Natural Killer Cell Therapeutics Product Offered
Table 67. Cytovia Therapeutics Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Cytovia Therapeutics Main Business
Table 69. Cytovia Therapeutics Latest Developments
Table 70. ImmunityBio, Inc. Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 71. ImmunityBio, Inc. Natural Killer Cell Therapeutics Product Offered
Table 72. ImmunityBio, Inc. Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. ImmunityBio, Inc. Main Business
Table 74. ImmunityBio, Inc. Latest Developments
Table 75. Biohaven Pharmaceuticals Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 76. Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Product Offered
Table 77. Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Biohaven Pharmaceuticals Main Business
Table 79. Biohaven Pharmaceuticals Latest Developments
Table 80. Fate Therapeutics Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 81. Fate Therapeutics Natural Killer Cell Therapeutics Product Offered
Table 82. Fate Therapeutics Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Fate Therapeutics Main Business
Table 84. Fate Therapeutics Latest Developments
Table 85. EMERcell Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 86. EMERcell Natural Killer Cell Therapeutics Product Offered
Table 87. EMERcell Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. EMERcell Main Business
Table 89. EMERcell Latest Developments
Table 90. Phio Pharmaceuticals Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 91. Phio Pharmaceuticals Natural Killer Cell Therapeutics Product Offered
Table 92. Phio Pharmaceuticals Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Phio Pharmaceuticals Main Business
Table 94. Phio Pharmaceuticals Latest Developments
Table 1. Natural Killer Cell Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Natural Killer Cell Therapeutics Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of NK Cell Therapies
Table 4. Major Players of NK Cell Directed Antibodies
Table 5. Natural Killer Cell Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global Natural Killer Cell Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 7. Global Natural Killer Cell Therapeutics Market Size Market Share by Type (2019-2024)
Table 8. Natural Killer Cell Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global Natural Killer Cell Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 10. Global Natural Killer Cell Therapeutics Market Size Market Share by Application (2019-2024)
Table 11. Global Natural Killer Cell Therapeutics Revenue by Player (2019-2024) & ($ millions)
Table 12. Global Natural Killer Cell Therapeutics Revenue Market Share by Player (2019-2024)
Table 13. Natural Killer Cell Therapeutics Key Players Head office and Products Offered
Table 14. Natural Killer Cell Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Natural Killer Cell Therapeutics Market Size by Region (2019-2024) & ($ millions)
Table 18. Global Natural Killer Cell Therapeutics Market Size Market Share by Region (2019-2024)
Table 19. Global Natural Killer Cell Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Natural Killer Cell Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Natural Killer Cell Therapeutics Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas Natural Killer Cell Therapeutics Market Size Market Share by Country (2019-2024)
Table 23. Americas Natural Killer Cell Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas Natural Killer Cell Therapeutics Market Size Market Share by Type (2019-2024)
Table 25. Americas Natural Killer Cell Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas Natural Killer Cell Therapeutics Market Size Market Share by Application (2019-2024)
Table 27. APAC Natural Killer Cell Therapeutics Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC Natural Killer Cell Therapeutics Market Size Market Share by Region (2019-2024)
Table 29. APAC Natural Killer Cell Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC Natural Killer Cell Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe Natural Killer Cell Therapeutics Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe Natural Killer Cell Therapeutics Market Size Market Share by Country (2019-2024)
Table 33. Europe Natural Killer Cell Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe Natural Killer Cell Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Natural Killer Cell Therapeutics
Table 39. Key Market Challenges & Risks of Natural Killer Cell Therapeutics
Table 40. Key Industry Trends of Natural Killer Cell Therapeutics
Table 41. Global Natural Killer Cell Therapeutics Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global Natural Killer Cell Therapeutics Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global Natural Killer Cell Therapeutics Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global Natural Killer Cell Therapeutics Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. Merck KGaA Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 46. Merck KGaA Natural Killer Cell Therapeutics Product Offered
Table 47. Merck KGaA Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. Merck KGaA Main Business
Table 49. Merck KGaA Latest Developments
Table 50. Bristol-Myers Squibb Company Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 51. Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Product Offered
Table 52. Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Bristol-Myers Squibb Company Main Business
Table 54. Bristol-Myers Squibb Company Latest Developments
Table 55. Glycostem Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 56. Glycostem Natural Killer Cell Therapeutics Product Offered
Table 57. Glycostem Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Glycostem Main Business
Table 59. Glycostem Latest Developments
Table 60. Sanofi Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 61. Sanofi Natural Killer Cell Therapeutics Product Offered
Table 62. Sanofi Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Sanofi Main Business
Table 64. Sanofi Latest Developments
Table 65. Cytovia Therapeutics Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 66. Cytovia Therapeutics Natural Killer Cell Therapeutics Product Offered
Table 67. Cytovia Therapeutics Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Cytovia Therapeutics Main Business
Table 69. Cytovia Therapeutics Latest Developments
Table 70. ImmunityBio, Inc. Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 71. ImmunityBio, Inc. Natural Killer Cell Therapeutics Product Offered
Table 72. ImmunityBio, Inc. Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. ImmunityBio, Inc. Main Business
Table 74. ImmunityBio, Inc. Latest Developments
Table 75. Biohaven Pharmaceuticals Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 76. Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Product Offered
Table 77. Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Biohaven Pharmaceuticals Main Business
Table 79. Biohaven Pharmaceuticals Latest Developments
Table 80. Fate Therapeutics Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 81. Fate Therapeutics Natural Killer Cell Therapeutics Product Offered
Table 82. Fate Therapeutics Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Fate Therapeutics Main Business
Table 84. Fate Therapeutics Latest Developments
Table 85. EMERcell Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 86. EMERcell Natural Killer Cell Therapeutics Product Offered
Table 87. EMERcell Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. EMERcell Main Business
Table 89. EMERcell Latest Developments
Table 90. Phio Pharmaceuticals Details, Company Type, Natural Killer Cell Therapeutics Area Served and Its Competitors
Table 91. Phio Pharmaceuticals Natural Killer Cell Therapeutics Product Offered
Table 92. Phio Pharmaceuticals Natural Killer Cell Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Phio Pharmaceuticals Main Business
Table 94. Phio Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Natural Killer Cell Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Natural Killer Cell Therapeutics Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Natural Killer Cell Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Natural Killer Cell Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Natural Killer Cell Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Natural Killer Cell Therapeutics Market Size Market Share by Type in 2023
Figure 10. Natural Killer Cell Therapeutics in Research & Academic Institutes
Figure 11. Global Natural Killer Cell Therapeutics Market: Research & Academic Institutes (2019-2024) & ($ millions)
Figure 12. Natural Killer Cell Therapeutics in Hospitals
Figure 13. Global Natural Killer Cell Therapeutics Market: Hospitals (2019-2024) & ($ millions)
Figure 14. Natural Killer Cell Therapeutics in Specialty Clinics
Figure 15. Global Natural Killer Cell Therapeutics Market: Specialty Clinics (2019-2024) & ($ millions)
Figure 16. Global Natural Killer Cell Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Natural Killer Cell Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Natural Killer Cell Therapeutics Market Size Market Share by Region (2019-2024)
Figure 19. Americas Natural Killer Cell Therapeutics Market Size 2019-2024 ($ millions)
Figure 20. APAC Natural Killer Cell Therapeutics Market Size 2019-2024 ($ millions)
Figure 21. Europe Natural Killer Cell Therapeutics Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Natural Killer Cell Therapeutics Market Size 2019-2024 ($ millions)
Figure 23. Americas Natural Killer Cell Therapeutics Value Market Share by Country in 2023
Figure 24. United States Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Natural Killer Cell Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Natural Killer Cell Therapeutics Market Size Market Share by Type (2019-2024)
Figure 30. APAC Natural Killer Cell Therapeutics Market Size Market Share by Application (2019-2024)
Figure 31. China Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 35. India Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Natural Killer Cell Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Natural Killer Cell Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Natural Killer Cell Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 41. France Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Natural Killer Cell Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Natural Killer Cell Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Natural Killer Cell Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 54. APAC Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 55. Europe Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 57. United States Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 58. Canada Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 59. Mexico Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 60. Brazil Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 61. China Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 62. Japan Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 63. Korea Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 65. India Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 66. Australia Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 67. Germany Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 68. France Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 69. UK Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 70. Italy Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 71. Russia Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 72. Egypt Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 73. South Africa Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 74. Israel Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 75. Turkey Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 77. Global Natural Killer Cell Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Natural Killer Cell Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Natural Killer Cell Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Natural Killer Cell Therapeutics Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Natural Killer Cell Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Natural Killer Cell Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Natural Killer Cell Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Natural Killer Cell Therapeutics Market Size Market Share by Type in 2023
Figure 10. Natural Killer Cell Therapeutics in Research & Academic Institutes
Figure 11. Global Natural Killer Cell Therapeutics Market: Research & Academic Institutes (2019-2024) & ($ millions)
Figure 12. Natural Killer Cell Therapeutics in Hospitals
Figure 13. Global Natural Killer Cell Therapeutics Market: Hospitals (2019-2024) & ($ millions)
Figure 14. Natural Killer Cell Therapeutics in Specialty Clinics
Figure 15. Global Natural Killer Cell Therapeutics Market: Specialty Clinics (2019-2024) & ($ millions)
Figure 16. Global Natural Killer Cell Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Natural Killer Cell Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Natural Killer Cell Therapeutics Market Size Market Share by Region (2019-2024)
Figure 19. Americas Natural Killer Cell Therapeutics Market Size 2019-2024 ($ millions)
Figure 20. APAC Natural Killer Cell Therapeutics Market Size 2019-2024 ($ millions)
Figure 21. Europe Natural Killer Cell Therapeutics Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Natural Killer Cell Therapeutics Market Size 2019-2024 ($ millions)
Figure 23. Americas Natural Killer Cell Therapeutics Value Market Share by Country in 2023
Figure 24. United States Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Natural Killer Cell Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Natural Killer Cell Therapeutics Market Size Market Share by Type (2019-2024)
Figure 30. APAC Natural Killer Cell Therapeutics Market Size Market Share by Application (2019-2024)
Figure 31. China Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 35. India Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Natural Killer Cell Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Natural Killer Cell Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Natural Killer Cell Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 41. France Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Natural Killer Cell Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Natural Killer Cell Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Natural Killer Cell Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Natural Killer Cell Therapeutics Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 54. APAC Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 55. Europe Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 57. United States Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 58. Canada Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 59. Mexico Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 60. Brazil Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 61. China Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 62. Japan Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 63. Korea Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 65. India Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 66. Australia Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 67. Germany Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 68. France Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 69. UK Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 70. Italy Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 71. Russia Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 72. Egypt Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 73. South Africa Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 74. Israel Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 75. Turkey Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Natural Killer Cell Therapeutics Market Size 2025-2030 ($ millions)
Figure 77. Global Natural Killer Cell Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Natural Killer Cell Therapeutics Market Size Market Share Forecast by Application (2025-2030)
